Login / Signup

Attenuated humoral immune response following anti-SARS-CoV-2 vaccine in heavily pretreated patients with multiple myeloma and AL amyloidosis.

Neta Schiller SaltonMoran SzwarcwortInna TzoranNetanel A HorowitzTsila ZukermanNurit HoreshYael Shachor-MeyouhasKhetam HusseinNoa Lavi
Published in: American journal of hematology (2021)
Keyphrases
  • immune response
  • multiple myeloma
  • sars cov
  • respiratory syndrome coronavirus
  • dendritic cells
  • toll like receptor